The Supreme Court is poised to consider California v. Texas, which will decide the fate of the Affordable Care Act (ACA) — their decision could threaten health coverage for millions of people with pre-existing conditions, including ovarian cancer. OCRA is vigilantly monitoring this upcoming decision, and preparing strategies for addressing any outcomes that may threaten … Continued
There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, PhD, and her team in the Daniel J. Powell Lab at the University of Pennsylvania’s Ovarian Cancer Research Center, have set out to answer. They … Continued
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA listening session in the video below.
It’s been an incredibly busy end of summer/beginning of fall here at OCRA with a double header of Ovarian Cancer Awareness Month and our Uniting for Hope Ovarian Cancer National Conference. We’ve learned so much and strengthened our community. Here are just some of the ways: RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS OCRA HEROES EVENTS WAYS TO … Continued
What a whirlwind! You heard a lot from us this September, and we want to take just a moment to tell you how grateful we are for your support throughout Ovarian Cancer Awareness Month. With your help, we surpassed our fundraising goal, raising more than $235,000—an incredible achievement that will have a tangible effect in … Continued
Some well-known people with deeply personal connections to ovarian cancer have echoed what we’ve been saying all September…this disease is a beast. And it doesn’t get talked about enough. Research for better treatments and a cure doesn’t get the funding it deserves. What we all deserve. Listen to what they have to say, and what draws them … Continued
An important victory for the ovarian cancer community came in 2006 when Congress passed Johanna’s Law. What is Johanna’s Law? Also known as The Gynecologic Cancer Education and Awareness Act, the legislation supports a variety of programs, research projects and activities at Centers for Disease Control and Prevention (CDC) aimed at educating healthcare providers and … Continued
In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or possibly delay, the onset of the disease. “We found there were various genes that would help the process along, but interestingly, there were other genes … Continued
Ovarian Cancer Research Alliance (OCRA) is thrilled to announce a groundbreaking partnership with Microsoft’s AI for Health initiative. This unique collaboration will help OCRA accelerate ovarian cancer research by harnessing the power of data science and Artificial Intelligence (AI). With the support of Microsoft’s AI for Health initiative, a $60 million, five-year program, select OCRA grantees can utilize Microsoft’s … Continued
This September, Newk’s Cares, the ovarian cancer awareness movement founded by fast-casual restaurant Newk’s Eatery, will honor the legacy of late co-founder Lori Newcomb with a series of meaningful initiatives online and at all 100+ restaurant locations across the country. Newk’s Cares was founded after Lori was diagnosed with Stage IIIC ovarian cancer in 2013. Her vision and dedication has … Continued
For someone who has spent four decades blazing trails in ovarian cancer research and women’s healthcare, it might seem odd that the one word to sum up Dr. Jonathan Berek’s wide range of experiences and contributions would be ‘communication.’ But the conveying of information in empathetic, successful, understandable and compelling ways has been at the … Continued
(July 27, 2020) Research from the Ovarian Cancer Association Consortium (OCAC) found that “using menopausal hormone therapy prior to diagnosis extends ovarian cancer survival.” This was found through a comprehensive analysis involving 6,419 post-menopausal women with ovarian carcinoma. Study authors concluded, “This large study is consistent with prior smaller studies, and further work is needed … Continued
Get email updates about research news, action alerts, and ways to join the fight.
